1-20 of 68
Keywords: Immunotherapy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology 1–18.
Published Online: 11 November 2024
... was examined to gain insight into the tumor microenvironment (TME) in different cancers. The results of the bioinformatic analysis were validated using immunotherapy clinical trials and pathological specimens. CCK-8 and Transwell assay experiments were performed to investigate the biological function of ESCO2...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology 1–25.
Published Online: 09 October 2024
... complicates immunotherapy. Key Messages: The infiltration of cytotoxic CD8 + T cells and Th1 cells correlates with better outcomes, while elevated T regs and TAMs promote tumor growth, metastasis, and resistance. TANs and natural killer (NK) cells exhibit dual roles, with higher NK cell levels linked...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal: Oncology
Oncology (2023) 101 (3): 159–165.
Published Online: 07 March 2023
.... 2022 Hodgkin lymphoma Lymphoma Chemoimmunotherapy Systemic therapy Immunotherapy Decision-making Experts in the current decision-making analysis proposed prednisone, vinblastine, adriblastin, gemcitabine [ 28 ] or cyclophosphamide, adriblastin, vincristine, prednisone [ 29 ] for those...
Journal Articles
Journal: Oncology
Oncology (2023) 101 (5): 283–291.
Published Online: 19 January 2023
... with immunotherapy with so far conflicting results. These two studies have in common the fact that they have analyzed the data of patients treated with different immunotherapy drugs and in different lines of treatment. The first of these studies was published in 2020 and showed that serum albumin levels and PNI...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2022) 100 (5): 290–302.
Published Online: 29 March 2022
... nonampullary duodenal adenocarcinoma Microsatellite instability Prognosis Immunotherapy Small bowel adenocarcinoma (SBA) is rare compared with other gastrointestinal cancers, and primary small bowel malignancies are even rarer, accounting for less than 5% of all gastrointestinal tumors [1...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2021) 99 (5): 310–317.
Published Online: 09 March 2021
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Fibrolamellar carcinoma 5-FU Interferon Nivolumab Immunotherapy With fewer than 200 new cases per year worldwide, fibrolamellar carcinoma (FLC) is an extremely...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2020) 98 (11): 749–754.
Published Online: 14 July 2020
... as an intravenous formulation as well as an oral formulation, with response rates of 6–12% in chemorefractory disease and 15–37% in chemosensitive disease. Immunotherapy has recently been approved as a first-line agent in metastatic SCLC in combination with chemotherapy. It is also approved as a third-line agent...